Back to Search
NIRAMOL SAVARAJ, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1982654141Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
F5367(TX)
Research & Publications (20)
Procollagen alpha 1 type 1: a potential aide in histopathological grading of glioma.
PMID 16305983·Cancer Invest·2005
8-other
Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells.
PMID 16032782·Free Radic Res·2005
4-observational
Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine.
PMID 12792791·Int J Oncol·2003
8-other
Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
PMID 19570948·Mol Pharmacol·2009
4-observational
Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins.
PMID 18585380·Eur J Pharmacol·2008
8-other
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
PMID 18566221·Mol Cancer Ther·2008
8-other
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1.
PMID 18523133·Mol Pharmacol·2008
8-other
Topoisomerase I inhibitors for the treatment of brain tumors.
PMID 18471044·Expert Rev Anticancer Ther·2008
6-review
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
PMID 18025288·Mol Cancer Ther·2007
8-other
The roles of copper transporters in cisplatin resistance.
PMID 17318448·Cancer Metastasis Rev·2007
6-review
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
PMID 17308069·Mol Cancer Ther·2007
8-other
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
PMID 17051317·J Neurooncol·2007
3-trial
Pegylated arginine deiminase: a novel anticancer enzyme agent.
PMID 16787144·Expert Opin Investig Drugs·2006
4-observational
Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers.
PMID 16652372·Mol Carcinog·2006
6-review
Molecular cloning of Chinese hamster 1q31 chromosomal fragile site DNA that is important to mdr1 gene amplification reveals a novel gene whose expression is associated with spermatocyte and adipocyte differentiation.
PMID 16545529·Gene·2006
7-preclinical
Association of fragile site-associated (FSA) gene expression with epithelial differentiation and tumor development.
PMID 16386706·Biochem Biophys Res Commun·2006
7-preclinical
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
PMID 16234528·J Clin Oncol·2005
3-trial
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.
PMID 16033649·Mol Cancer·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1201 NW 16TH ST, D1010
MIAMI, FL 33125 - Phone
- (305) 575-3143
Quick Facts
- NPI
- 1982654141
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile